162 related articles for article (PubMed ID: 26882145)
1. A new PK equivalence test for a bridging study.
Novick SJ; Zhang X; Yang H
J Biopharm Stat; 2016; 26(5):992-1002. PubMed ID: 26882145
[TBL] [Abstract][Full Text] [Related]
2. Comparing the concentration curves directly in a pharmacokinetics, bioavailability/bioequivalence study.
Liao JJ
Stat Med; 2005 Mar; 24(6):883-91. PubMed ID: 15558699
[TBL] [Abstract][Full Text] [Related]
3. Simulation study of the relationship between variation in bioavailability and clinical equivalence using a direct link model.
Matsumoto Y; Shimizu M; Ogata H
Int J Clin Pharmacol Ther; 2005 Jan; 43(1):57-62. PubMed ID: 15704616
[TBL] [Abstract][Full Text] [Related]
4. Inference of bioequivalence for log-normal distributed data with unspecified variances.
Xu S; Hua SY; Menton R; Barker K; Menon S; D'Agostino RB
Stat Med; 2014 Jul; 33(17):2924-38. PubMed ID: 24403216
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic comparisons between two formulations containing 100 mg of miglitol in healthy male Korean volunteers: a randomized, open-label, single-dose, two-period, two-sequence crossover bioequivalence study.
Choi HG; Jeon JY; Im YJ; Kim Y; Jang H; Kang S; Kim KH; Chae SW; Lee SY; Kim MG
Int J Clin Pharmacol Ther; 2014 Jan; 52(1):55-63. PubMed ID: 24290415
[TBL] [Abstract][Full Text] [Related]
6. Does the placebo effect modulate drug bioavailability? Randomized cross-over studies of three drugs.
Hammami MM; Yusuf A; Shire FS; Hussein R; Al-Swayeh R
J Negat Results Biomed; 2017 May; 16(1):10. PubMed ID: 28535819
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics study of two different clindamycin capsule formulations: a randomized, two-period, two-sequence, two-way crossover clinical trial in healthy volunteers.
Sanki UK; Mandal BK; Chandrakala V
Arzneimittelforschung; 2011; 61(9):538-43. PubMed ID: 22029232
[TBL] [Abstract][Full Text] [Related]
9. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
[TBL] [Abstract][Full Text] [Related]
10. Considerations for metabolite pharmacokinetic data in bioavailability/bioequivalence assessments. Overview of the recent trends.
Srinivas NR
Arzneimittelforschung; 2009; 59(4):155-65. PubMed ID: 19517891
[TBL] [Abstract][Full Text] [Related]
11. Use of Bayesian methods for multivariate bioequivalence measures.
Molina de Souza R; Achcar JA; Martinez EZ
J Biopharm Stat; 2009; 19(1):42-66. PubMed ID: 19127466
[TBL] [Abstract][Full Text] [Related]
12. Dissolution modeling of bead formulations and predictions of bioequivalence for a highly soluble, highly permeable drug.
Sperry DC; Thomas SJ; Lobo E
Mol Pharm; 2010 Oct; 7(5):1450-7. PubMed ID: 20704266
[TBL] [Abstract][Full Text] [Related]
13. Metrics for the evaluation of bioequivalence of modified-release formulations.
Endrenyi L; Tothfalusi L
AAPS J; 2012 Dec; 14(4):813-9. PubMed ID: 22910857
[TBL] [Abstract][Full Text] [Related]
14. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of direct curve comparison metrics applied to pharmacokinetic profiles and relative bioavailability and bioequivalence.
Marston SA; Polli JE
Pharm Res; 1997 Oct; 14(10):1363-9. PubMed ID: 9358548
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and bioequivalence study of two cetirizine hydrochloride formulations in healthy Chinese male volunteers.
Xu FG; Liu Y; Zhang ZJ; Tian Y; Chen Y
Arzneimittelforschung; 2009; 59(9):440-4. PubMed ID: 19856790
[TBL] [Abstract][Full Text] [Related]
17. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?
Mamidi RN; Weng S; Stellar S; Wang C; Yu N; Huang T; Tonelli AP; Kelley MF; Angiuoli A; Fung MC
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1173-84. PubMed ID: 20661737
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and bioequivalence study of aniracetam after single-dose administration in healthy Chinese male volunteers.
Tian Y; Zhang JJ; Feng SD; Zhang ZJ; Chen Y
Arzneimittelforschung; 2008; 58(10):497-500. PubMed ID: 19025058
[TBL] [Abstract][Full Text] [Related]
20. Bayesian approach to average bioequivalence using Bayes' factor.
Ghosh P; Khattree R
J Biopharm Stat; 2003 Nov; 13(4):719-34. PubMed ID: 14584718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
